Sort
53,477 grants matching “addiction”
Targeting Endosomal GPCR (eGPCR) Signaling Platforms for the Treatment of Chronic Pain
$1,307,330Edward Wu · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Development of a Non-Paralyzing BoNT-based Biopharmaceutical for the Treatment of Neuropathic Pain
$1,307,330Edward Wu · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
GENETICS OF VULNERABILITY TO NICOTINE ADDICTION
$1,305,875Washington University · R01 · FY2003 · DA
Workforce and System Change to Treat Adolescent Opioid Use Disorder within Integrated Pediatric Primary Care
$1,304,874Leslie A. Hulvershorn · Indiana University Indianapolis · R33 · FY2024 · DA
The National Drug Abuse Treatment Clinical Trials Network (U10)
$1,304,388Roger D. Weiss · Mclean Hospital · U10 · FY2010 · DA
Examining the quality of opioid use disorder treatment in a Medicaid research network
$1,304,165Julie Marie Donohue · University Of Pittsburgh At Pittsburgh · R01 · FY2020 · DA
Use of advanced analytics to understand brain-behavior screen media activity relationships in ABCD data
$1,303,989Marc N Potenza · Yale University · RF1 · FY2021 · MH
Development of a flagellin-cocaine conjugate vaccine
$1,303,127Steven B. Mizel · Wake Forest University Health Sciences · RC2 · FY2009 · DA
Improving the efficacy of anti-nicotine immunotherapy
$1,303,043Alexey G Mukhin · Duke University · RC2 · FY2009 · DA
Alcohol Pharmacokinetics and Pharmacodynamics in Humans
$1,302,830Vijay Arjun Ramchandani · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2013 · AA
Modulation of cancer induced immune suppression via inhibition of SCD1
$1,301,808Karen E Hayes · Modulation Therapeutics, Inc. · R44 · FY2023 · CA
17/24 Healthy Brain and Child Development National Consortium
$1,301,346Sylia Wilson · University Of Minnesota · U01 · FY2023 · DA
Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care
$1,300,572Joshua D Lee · New York University School Of Medicine · R01 · FY2014 · AA
MANAGEMENT OF UNHEALTHY OPIOID AND POLYSUBSTANCE USE AMONG PATIENTS IN PRIMARY CARE SETTINGS. FY22. POP 9/15/22 - 9/14/27.
$1,299,926Eve Jelstrom · The Emmes Company, Llc · N01 · FY2022 · DA
Southern Consortium Node of the Clinical Trials Network
$1,299,037Kathleen Theresa Brady · Medical University Of South Carolina · U10 · FY2013 · DA
Families left behind: Addressing prolonged grief and substance use disorders among people bereaved by drug overdose deaths
$1,298,766Karen Chan Osilla · Stanford University · R61 · FY2024 · DA
Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS
$1,298,700Kanna Hayashi · Simon Fraser University · U01 · FY2021 · DA
Vancouver Drug Users Study: The Impacts of Evolving Drug Use Patterns on HIV/AIDS
$1,298,700Kanna Hayashi · Simon Fraser University · U01 · FY2023 · DA
Neurobiology of Addiction Research Center
$1,297,821Peter W Kalivas · Medical University Of South Carolina · P50 · FY2017 · DA
Neurobiology of Addiction Research Center
$1,297,821Peter W Kalivas · Medical University Of South Carolina · P50 · FY2014 · DA
Biological Determinants of Alcohol Action in Minorities
$1,297,595Howard University · P20 · FY2004 · AA
Biological Determinants of Alcohol Action in Minorities
$1,297,595Howard University · P20 · FY2005 · AA
Translational Addiction Sciences Center
$1,297,576Kathryn A. Cunningham · University Of Texas Med Br Galveston · P50 · FY2014 · DA
IGF::OT::IGF: Informatics Support for NIDA. September 23, 2017 - September 22, 2018. N01DA-17-8940.
$1,296,714Robert Keilman · Calibre Systems, Inc. · N01 · FY2018 · DA
HIV Testing and Treatment to Prevent Onward HIV Transmission among High-risk MSM
$1,295,482Ann C Duerr · Fred Hutchinson Cancer Research Center · R01 · FY2012 · DA